Literature DB >> 23033129

Lung morphology and growth of rats exposed to tobacco smoke and alcohol.

Karla Luciana Magnani1, Daniele Cristina Cataneo, Vera Luiza Capelozzi, Julio Defaveri, Erica Nishida Hasimoto, Antônio José Maria Cataneo.   

Abstract

PURPOSE: Investigate the morphological effects of chronic exposure to tobacco smoke inhalation and alcohol consumption on the lungs and on the growth of rats.
METHODS: Sixty male Wistar rats were divided into four groups: control, tobacco, alcohol, tobacco + alcohol, for a period of study 260 days. Morphological analysis was conducted by optical and electron microscopy. Rat growth was investigated by measuring the snout-anus length, body mass index and body weight.
RESULTS: The three groups exposed to the drugs presented lower growth and lower weight than the control group. The percentages of alveolitis, bronchiolitis and the mean alveolar diameter were greater, particularly in the groups exposed to tobacco smoke, but were not significantly different from the control group. Electron microscopy revealed more intense apoptotic and degenerative lesions in the smoking group, while degenerative lesions in the lamellar bodies were more intense with the association of both drugs.
CONCLUSIONS: This experimental model showed morphological alterations observed by electron microscopy, principally due to tobacco smoke exposure. Alcohol and tobacco hindered the growth of rats, such that tobacco showed a greater effect on body length and alcohol on body weight.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23033129     DOI: 10.1590/s0102-86502012001000004

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  3 in total

Review 1.  Early life influences on the development of chronic obstructive pulmonary disease.

Authors:  Janet Stocks; Samatha Sonnappa
Journal:  Ther Adv Respir Dis       Date:  2013-02-25       Impact factor: 4.031

2.  Second hand tobacco smoke adversely affects the bone of immature rats.

Authors:  Rodrigo César Rosa; Sângela Cunha Pereira; Fabrizio Antônio Gomide Cardoso; Abadio Gonçalves Caetano; Hildemberg Agostinho Rocha de Santiago; José Batista Volpon
Journal:  Clinics (Sao Paulo)       Date:  2017-12       Impact factor: 2.365

3.  The histone deacetylase inhibitor, romidepsin, as a potential treatment for pulmonary fibrosis.

Authors:  Franco Conforti; Elizabeth R Davies; Claire J Calderwood; Thomas H Thatcher; Mark G Jones; David E Smart; Sumeet Mahajan; Aiman Alzetani; Tom Havelock; Toby M Maher; Philip L Molyneaux; Andrew J Thorley; Teresa D Tetley; Jane A Warner; Graham Packham; A Ganesan; Paul J Skipp; Benjamin J Marshall; Luca Richeldi; Patricia J Sime; Katherine M A O'Reilly; Donna E Davies
Journal:  Oncotarget       Date:  2017-07-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.